ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

Pancreatic Cancer: Risk Factors, Symptoms and Early Diagnoses

July 11, 2023
By The Let's Win Team

The survival of pancreatic cancer is 12%, making it one of the deadliest cancers of our time. As a result, understanding the symptoms, risks factors, as well and the benefit of an early diagnosis is key.

Pancreatic Cancer: Risk Factors, Symptoms and Early Diagnoses

This is thesecond blogfrom Let’s Win Pancreatic Cancer. To learn about the free resources and support they provide to patients and providers within the pancreatic cancer community, read the first onehere.

Approximately 64,000 patients will be diagnosed with pancreatic cancer this year. According to the National Cancer Institute, the annual rate of new cases of pancreatic cancer was 13.3 per 100,000 individuals from 2016 to 2020. The rate is higher for Black Americans (16.2%). The survival rate for pancreatic cancer is just above 12%, making it one of the deadliest cancers of our time.

What makes pancreatic cancer so lethal? The answer is complex. For starters, there is currently no standard of care screening for the disease. Additionally, the most common symptoms—back or abdominal pain and digestive issues—are common in many less serious conditions. The location of the pancreas within the body also makes it difficult to detect tumors during a physical examination. As a result, pancreatic cancer is often diagnosed at an advanced stage, when it is much harder to treat. Lastly, the stroma, a dense outer layer which surrounds the tumor, makes it resistant to treatment. All of this begs the question, how can we identify and diagnose this dangerous disease sooner?

The wealth of information available on the Let’s Win platform can help educate patients and their healthcare providers about therisk factors and symptoms of pancreatic cancer, thereby increasing the chances of earlier diagnosis and better treatment options. If more people are aware of these critical facts, the outcome for patients with pancreatic cancer could improve.

Pancreatic Cancer Risk Factors

Understanding the risk factors associated with pancreatic cancer enables patients and their doctors to act quickly when symptoms arise. These risk factors are broken into three groups: lifestyle, family history/genetic mutations, and diseases.

Lifestyle

The lifestyle factors include:

  • Smoking: The risk for pancreatic cancer is twice as likely in smokers as it is in nonsmokers.
  • Obesity: Individuals with a BMI >30 are 20% more likely to get pancreatic cancer. Reducing the occurrence of obesity and keeping any related diabetes symptoms in check can reduce an individual’s risk for pancreatic cancer.
  • Heavy alcohol consumption: Studies indicate that heavy alcohol consumption can lead to various cancers, including pancreatic cancer.
  • Aging: Two-thirds of pancreatic cancer patients are over the age of 65. However, aging is a factor beyond our control.

Family History/Genetic Mutations

Family history is an important risk factor. Approximately 10% of pancreatic cancer cases are hereditary, where the patient has a direct relation—a parent, sibling, or child—that has had the disease. About7% of patients with a family history have a known genetic mutation that increases their risk. The best-known mutations are BRCA1, BRCA2, and PALB2, but there are also other mutations that increase an individual’s risk of pancreatic cancer. Even though genetic mutations and family history are risk factors that cannot be prevented, their effects can be reduced through genetic testing, and understanding one’s family history. Identifying genetic mutations can influence treatment choices while genetic testing is now standard of care for all pancreatic cancer diagnoses.

Diseases

Diseases that are common risk factors for pancreatic cancer include:

  • Pancreatitis: Inflammation of thepancreas, particularly chronic pancreatitis, is related to pancreatic cancer. In some cases, hereditary factors can contribute to chronic pancreatitis.
  • Pancreatic cysts: Theseare very common and in most cases, are not cancerous. But two types—intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic pancreatic neoplasms (MCPNs)—tend to develop into cancer over time.
  • Diabetes: This isthe most notable disease risk factor for pancreatic cancer. Nearly 1 in 4 people diagnosed with pancreatic cancer have diabetes. More importantly, new-onset diabetes may be a symptom of pancreatic cancer; particularly in patients over 50 years of age and when associated with weight loss rather than the typical weight gain, in individuals with diabetes. Researchers believe that as the tumor takes over the pancreas, it leads to an ineffective production of insulin and insulin resistance, which results in diabetes. People who are newly diagnosed with diabetes may want to discuss this relationship with their doctors and arrange for further testing.

Symptoms of Pancreatic Cancer

Much of the difficulty in diagnosing pancreatic cancer comes from the lack of telltale signs for the disease. The most common symptoms of pancreatic cancer are also symptoms of many other less lethal gastrointestinal (GI) or muscular conditions. They include:

  • Back and abdominal pain
  • GI problems, including indigestion, reflux, bloating, nausea, and loss of appetite
  • Jaundice
  • Dark urine and pale stools
  • Itchy skin

The location of the tumor impacts the symptoms a patient experiences. A tumor that presses on the stomach can cause nausea and loss of appetite, while a tumor wrapped around the celiac nerves causes abdominal pain or back pain. A tumor blocking the bile duct causes jaundice, itchy skin, and discolored urine and stool. This further complicates the diagnosis process because jaundice can occur as the final symptom in a patient with stage IV pancreatic cancer; or it could be one the first symptoms. Other, less-common symptoms include:

  • Fatigue
  • Loss of appetite
  • Taste aversions (eg: a sudden dislike of coffee, smoking, or wine)
  • Blood clots
  • Fatty deposits under the skin
  • Acute pancreatitis attacks
  • Depression

How Oncologists Can Facilitate Earlier Diagnoses

By the time a patient sees an oncologist, he or she has already been diagnosed with pancreatic cancer—and it can be devastating. However, sharing information about risk factors and symptoms of pancreatic cancer is one way we can all play a part in earlier diagnoses, particularly for people with a family history of the disease. Let’s Win consolidates a wide spectrum of information, resources, and support for those at risk of developing the disease, those who have already been diagnosed, and those who are supporting and treating them.

More than anything else, it is important for providers and patients to advocate for each other and themselves when something doesn’t seem right. Early detection can lead to a better outcome, which can make all the difference in the world.

Related Content

Transforming Oncology Authorization Through Clinical and Revenue Cycle CollaborationACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Rachel Radwan

June 29, 2026

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

A Leadership Playbook for Responsible AI AdoptionACCCBuzz Blog

A Leadership Playbook for Responsible AI Adoption

June 4, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Each year, the NCCN State Oncology Society Forum is thoughtfully organized to foster meaningful collaboration and forge common bonds to advance dignity and fair access to cancer care. In this blog, Sean T. McCarson shares key insights from stakeholders across the oncology policy landscape at this year's meeting.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

Data-Driven Toxicity Management for ADCs – [Video Podcast] Ep. 235

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login